Heart-type fatty acid binding protein HFABP detection kit

Abstract

The invention discloses a heart-type fatty acid binding protein HFABP detection kit. The kit comprises a box body, wherein a shell is adhered to the surface of the box body. The rear side of the top of the shell is flexibly connected with a box cover. A fixing plate is bonded to the bottom of the front face of the box cover. The inner side of the fixed plate is rotationally connected with a rotating rod through a bearing. Through arranging a rotating rod, a sleeve and the fixed plate, the rotating plate can conveniently drive the inserting plate to rotate. Through arranging a slot, the rotating plate can be conveniently embedded into the slot. Through a through groove and a sliding groove, the outer surface of the sliding plate can conveniently slide on the inner surface of the sliding groove. The sliding plate drives the limiting column to guide leftwards through the counter-acting force of the spring, and at the same time, the inserting rod is driven to guide leftwards, so that the inserting rod extends into an inserting hole in the left side of the lock body. By means of the structure, the detection kit has the advantages that the protection effect of the detection reagent bottle is improved, the problem that an existing detection kit is poor in protection effect is solved, and therefore the detection reagent bottle is convenient to use.

Description

technical field [0001] The invention relates to a detection kit, in particular to a detection kit for heart-shaped fatty acid binding protein HFABP. Background technique [0002] Heart-type fatty acid binding protein is a new type of small cytoplasmic protein that is abundant in the heart. It is highly cardiac-specific, but it is also expressed at low concentrations in tissues other than the heart. After myocardial ischemic injury, it can be diagnosed as early as chest pain. Found in blood 1-3 hours after onset, peaks at 6-8 hours and normalizes plasma levels within 24-30 hours Cardiac fatty acid-binding cytosolic protein consists of 132 amino acids and is one of the most abundant proteins in the heart 1. The current clinical treatment detection methods are divided into two methods: chromatography detection and instrument detection. The use of chromatography detection methods requires test paper or reagents. The current detection reagent bottles are packaged with detection k...

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to provide the heart-type fatty acid binding protein HFABP detection kit, which has the advantage of improving the protection effect of the detection reagent bottle, and solves the problem that the protection effect of the existing detection kit is relatively poor

Images